Skip to main content
Glarner Kantonalbank logo

Glarner Kantonalbank — Investor Relations & Filings

Ticker · GLKBN ISIN · CH0189396655 LEI · 549300AY225QXN79YF87 SW Financial and insurance activities
Open in API
Filings indexed 226 across all filing types
Latest filing 2021-07-07 Major Shareholding Noti…
Country CH Switzerland
Listing SW GLKBN

About Glarner Kantonalbank

https://glkb.ch/

Glarner Kantonalbank is a universal bank providing a wide range of financial products and services to private and corporate customers. The bank's core activities are focused on the mortgage and savings business, complemented by asset management and investment services. It offers bundled products, such as the "Glarner Set," which combines accounts, cards, and a benefits program. The institution also operates "glarix," a digital banking platform that provides access to its services with attractive conditions, emphasizing its commitment to digital solutions.

Recent filings

Filing Released Lang Actions
Form 8.3 - Zürcher Kantonalbank: UDG Health
Major Shareholding Notification Classification · 99% confidence The document explicitly states it is a 'FORM 8.3' under the 'IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3'. This form details dealings (purchases, sales, interests, short positions) by a person (Zürcher Kantonalbank) with interests in relevant securities (UDG Health) during a takeover context. This type of filing, which reports insider/major shareholder transactions related to a specific corporate action (like a takeover bid, implied by the Irish Takeover Panel reference), most closely aligns with the definition of Director's Dealing (DIRS) or a specific regulatory filing. Since it is a mandatory disclosure of personal share transactions by an entity holding a significant interest (1% or more) during a potential takeover scenario, it falls under the scope of insider/director dealings reporting, even though the filer is a bank and not strictly a director. Given the options, 'DIRS' (Director's Dealing) is the closest fit for mandatory transaction disclosure by an insider/major holder. However, since it is a specific regulatory filing mandated by the Irish Takeover Panel (Form 8.3), and 'DIRS' usually implies directors, 'RNS' (Regulatory Filings) is a strong fallback. Reviewing the definitions: DIRS is for 'personal share transactions by company directors and executives (insider trades)'. This is a major shareholder disclosure during a takeover. Given the highly specific nature of Form 8.3, which is a mandatory disclosure of interests/dealings, it is a specific type of insider reporting. If we must choose the best fit among the provided codes, 'DIRS' covers insider trading disclosures. If it were a general announcement, RNS would apply. Since it details specific dealings and interests, DIRS is plausible, but 'TAR' (M&A Activity) is also relevant due to the Takeover Panel context. However, Form 8.3 is fundamentally a disclosure of *dealings*. Let's re-evaluate: Form 8.3 is a mandatory disclosure of dealings by a person holding 1% or more during an offer period. This is a specific type of insider transaction reporting. 'DIRS' is the closest category for transaction reporting by significant holders/insiders. If the document was purely about the takeover bid itself, TAR would fit. Since it is about the *dealings* of a major holder, DIRS is selected as the best fit for transaction disclosure, although RNS is a possibility if DIRS is too narrow.
2021-07-07 English
Form 8.3 - Zürcher Kantonalbank: UDG Health
Director's Dealing Classification · 98% confidence The document explicitly states it is a 'FORM 8.3' under the 'IRISH TAKEOVER PANEL' rules, disclosing 'DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE'. This type of filing relates to insider transactions or significant changes in holdings during a takeover period, which falls under the scope of director/insider dealings or major shareholding notifications. Since the filing details transactions by Zürcher Kantonalbank (a major shareholder/entity) in UDG Health securities, it is most closely aligned with reporting personal share transactions by executives/directors or significant ownership changes. The definition for 'Director's Dealing' (DIRS) covers personal share transactions by directors and executives (insider trades). While this is a Form 8.3 related to a takeover, the core activity reported is a dealing in securities by an interested party. 'Major Shareholding Notification' (MRQ) is also relevant, but DIRS often captures specific transaction disclosures like this, especially when related to insider activity or significant holders during corporate actions. Given the context of takeover rules and dealing disclosure, 'DIRS' (Director's Dealing) is the closest fit among the provided options for reporting specific security transactions by an interested party, although 'MRQ' (Major Shareholding Notification) is a close secondary possibility. However, Form 8.3 is a specific takeover-related disclosure of dealings, which strongly suggests insider/significant holder activity reporting. I will classify this as DIRS as it reports specific dealings by an interested party.
2021-07-06 English
Form 8.3 - Zürcher Kantonalbank: UDG Healthcare plc
Major Shareholding Notification Classification · 99% confidence The document explicitly states it is a 'FORM 8.3' from the 'IRISH TAKEOVER PANEL' concerning 'DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE'. This form details transactions (dealings) by a person (Zürcher Kantonalbank) in the securities of another company (UDG Healthcare plc) during a potential takeover scenario. This type of filing, which reports personal share transactions by executives or major stakeholders, aligns most closely with the definition of Director's Dealing (DIRS), although it is specifically a takeover-related disclosure. Given the options, 'DIRS' covers insider/major shareholder transactions. However, since this is a specific regulatory filing related to takeover rules (Rule 8.3), and it details transactions by a major shareholder (1.19% interest), it is a form of insider/major shareholder transaction reporting. If 'DIRS' is interpreted broadly as insider/major shareholder transactions, it fits. If we consider the context of major shareholding changes, 'MRQ' (Major Shareholding Notification) is also relevant, but Form 8.3 is specifically about *dealings* during a bid period. Since the document details specific transactions ('Purchases and sales', 'Other dealings') by a person holding a significant stake (1.19%), and there isn't a specific code for 'Takeover Disclosure', 'DIRS' (Director's Dealing) is the closest fit for reporting executive/insider transactions, or 'MRQ' for major shareholding changes. Given the focus on specific dealings during a potential offer period, and the fact that Zürcher Kantonalbank is acting as a major shareholder/stakeholder, 'MRQ' (Major Shareholding Notification) is a strong candidate as it tracks changes in significant ownership. However, Form 8.3 is fundamentally about reporting *dealings* by a person with a 1% or more interest, which is a specific type of insider/major shareholder activity. Let's re-evaluate the definitions. 'DIRS' is for 'Report of personal share transactions by company directors and executives (insider trades)'. While Zürcher Kantonalbank might not be a director, it is reporting transactions as a major stakeholder (1.19%). 'MRQ' is for 'Notification of changes in significant share ownership levels (crossing thresholds)'. Since the document reports the *current* interest (1.19%) and the *dealings* that led to it, it functions as both. In the context of takeover rules, these disclosures are mandatory for anyone holding 1% or more. Given the explicit reporting of transactions and resulting position, 'MRQ' seems slightly more appropriate than 'DIRS' which usually implies directors/executives, unless Zürcher Kantonalbank is acting in a capacity that makes it an 'insider' in the context of the bid. Since it is a disclosure of a major holding and transactions by a party involved in a takeover, and 'MRQ' covers major shareholding notifications, I will select MRQ as the best fit for tracking significant ownership changes.
2021-07-05 English
Form 8.3 - Zürcher Kantonalbank: UDG Healthcare plc
Major Shareholding Notification Classification · 99% confidence The document explicitly states it is a 'FORM 8.3' from the 'IRISH TAKEOVER PANEL' regarding 'DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE'. This type of filing reports personal share transactions by significant holders, often in the context of a takeover or major corporate event. Reviewing the provided definitions, this activity—reporting personal share transactions by directors/executives or significant holders—most closely aligns with 'Director's Dealing' (DIRS), although Form 8.3 specifically relates to takeover rules and significant shareholdings (which might suggest MRQ). However, Form 8.3 is a specific regulatory disclosure related to insider/significant holder transactions during a bid period. Given the options, 'Director's Dealing' (DIRS) is the closest fit for reporting personal security transactions by an interested party, even if the context is a takeover bid. If the document were purely about crossing a major shareholding threshold outside a bid context, MRQ would be considered. Since it details specific dealings (purchases/sales/derivatives) by Zürcher Kantonalbank in UDG Healthcare plc securities, it falls under insider/significant transaction reporting. DIRS covers personal share transactions by directors and executives, which is the closest analogue for this type of transaction disclosure among the choices. Alternatively, since it is a specific regulatory filing related to a takeover, it could be RNS, but DIRS is more specific to the content type.
2021-07-02 English
Glarner Kantonalbank emittiert Tier-2-Anleihe (10NC5) uber 150 Millionen Franken
Capital/Financing Update Classification · 99% confidence The document is a news release from Glarner Kantonalbank dated June 24, 2021, announcing the issuance of a CHF 150 million Tier-2 bond (10NC5). It details the terms (price, interest rate, rating) and mentions the intention to call back a previous Tier-1 bond. This clearly falls under corporate financing activities, specifically debt issuance. Based on the provided definitions, 'Capital/Financing Update' (CAP) is the most appropriate classification for an announcement regarding the issuance of a new bond and the planned redemption of an old one.
2021-06-24 German
Glarner Kantonalbank (GLKB) und Leonteq gehen Kooperation ein
M&A Activity Classification · 99% confidence The document is explicitly labeled as an "Ad-hoc" announcement published on May 10, 2021, and states it is a "Veröffentlichung einer Ad-hoc-Mitteilung gemäss Art. 18 KR" (Publication of an ad-hoc announcement according to Art. 18 KR). The content details a new business cooperation agreement between Glarner Kantonalbank (GLKB) and Leonteq regarding pension solutions. This type of material, announcing significant, non-routine business developments outside of standard periodic financial reporting, fits best under the general category for regulatory announcements that are not specifically covered by other codes like 10-K, ER, or CAP. Since it is a general regulatory announcement that doesn't fit the specific definitions for M&A (TAR), Capital Change (CAP/SHA), or Director Dealing (DIRS), the most appropriate fallback is Regulatory Filings (RNS). The document length is short (3177 chars) and it is an announcement, not the full report itself.
2021-05-10 German

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.